KALA

Q: What is the price of Kala Pharmaceuticals (KALA) today?

The current price of Kala Pharmaceuticals (KALA) is $ 2.71, representing a -98.52% gain over the past year. The stock began the year trading around $ 0.56 and is currently priced at $ 2.71. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Kala Pharmaceuticals (KALA) pay dividends?

Kala Pharmaceuticals (KALA) did not pay dividends over the past year.

Kala Pharmaceuticals Inc.

Price

$ 2.71

return (12m)

-98.52%

p/e

4.25

p/bv

0.42

DIVIDEND YIELD

0.00%

KALA price

KALA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment KALA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-72.75%

3 months

-86.38%

1 year

-98.52%

2 years

-99.17%

5 years

-99.98%

10 years

0.00%

Fundamentals KALA

review the fundamentals of Kala Pharmaceuticals shares

P/E

4.25

Sector: -9.59 Industry: -9.59

P/S (PSR)

Sector: -138.14 Industry: -138.14

P/BV

0.42

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

7.27%

Sector: -31.16% Industry: -31.16%

ROE

9.86%

Sector: -31.19% Industry: -31.19%

ROIC

-270.85%

Sector: -2,596.17% Industry: -2,596.17%

NET MARGIN

0.00%

Sector: -39.99% Industry: -39.99%

GROSS MARGIN

0.00%

Sector: 37.30% Industry: 37.30%

OPERATING MARGIN

0.00%

Sector: -39.14% Industry: -39.14%

EV/EBITDA

3.33

Sector: -10.69 Industry: -10.69

EV/EBIT

3.53

Sector: -10.50 Industry: -10.50

PRICE-TO-ASSETS

0.31

Sector: 1.43 Industry: 1.43

BVPS

7.00

Sector: 1.96 Industry: 1.96

EPS

0.69

Sector: -1.07 Industry: -1.07

EQUITY-TO-ASSETS RATIO

0.74

Sector: 0.44 Industry: 0.44

LIABILITIES / ASSETS

0.26

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-28.33%

Sector: - Industry: -

FAIR VALUE OF Kala Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 2.71

Fair Value

$ 0.00

Upside/Downside Return potential.

284.68%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals KALA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	103.71	6.69	6.45%	2.31%	$ 542.92 B	21.76%
PFE	52.78	1.57	2.97%	6.90%	$ 141.82 B	18.60%
ABBV	535.81	-56.32	-10.51%	3.20%	$ 372.39 B	4.63%
NVO	26.47	6.33	23.91%	4.17%	$ 198.78 B	50.15%
AZN	91.32	5.94	6.50%	1.76%	$ 281.27 B	20.15%
GILD	79.63	6.87	8.63%	2.46%	$ 160.94 B	29.04%
BMY	43.39	5.78	13.32%	4.39%	$ 116.17 B	23.30%
ZTS	52.11	9.69	18.59%	2.74%	$ 31.32 B	26.57%
REGN	99.86	2.31	2.31%	0.51%	$ 72.62 B	20.17%
HALO	52.78	36.06	68.32%	0.00%	$ 7.92 B	39.83%
AMGN	96.87	19.17	19.79%	2.96%	$ 176.21 B	21.11%
MCK	55.17	-111.26	-201.68%	0.42%	$ 92.79 B	1.75%
HRMY	53.72	1.92	3.57%	0.00%	$ 1.75 B	15.08%
VRTX	107.61	5.73	5.33%	0.00%	$ 110.99 B	34.53%
CAH	114.64	-17.12	-14.93%	1.05%	$ 45.74 B	0.65%
ADMA	43.06	5.00	11.61%	0.00%	$ 1.95 B	39.59%
BIIB	88.77	1.52	1.71%	0.00%	$ 28.36 B	12.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

KALA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kala Pharmaceuticals

Kala Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2017

Time since IPO - 9 years

188

Employees

Kala Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.93 Millions, with shareholders equity totaling $7.00 Millions.

The company employs approximately 188 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kala Pharmaceuticals Inc. reported $- in revenue, generating net income of $-26.97 Millions.

Key financial metrics include a P/E ratio of 4.25, a price-to-book (P/B) ratio of 0.42, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KALA.

Market cap

$ 2.93 Millions

Net worth

$ 7.00 Millions

$ 7,000,000.00

Assets

$ 9.49 Millions

$ 9,490,000.00

Total Shares Outstanding

1.00 Million

1,000,000

Average Daily Trading Volume

$ 199.52 Thousand

$ 199,517.46

Sector

Health Care

Industry

Biotechnology

KALA

KALA revenue and profits

Financial Results KALA

DRAG THE FRAME TO SEE MORE DATA

KALA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.97 7,36% (12M)

P/E

55.17

0.42%

ROE

-201.68%

P/BV

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12M)

P/E

114.64

1.05%

ROE

-14.93%

P/BV

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12M)

P/E

103.71

2.31%

ROE

6.45%

P/BV

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12M)

P/E

-64.94

2.98%

ROE

-9.23%

P/BV

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12M)

P/E

91.32

1.76%

ROE

6.50%

P/BV

5.94

ABBV - AbbVie

$ 209.41 16,34% (12M)

P/E

535.81

3.20%

ROE

-10.51%

P/BV

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12M)

P/E

26.47

4.17%

ROE

23.91%

P/BV

6.33

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.97 7,36% (12 M)

P/L

55.17

0.42%

ROE

-201.68%

P/VP

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12 M)

P/L

114.64

1.05%

ROE

-14.93%

P/VP

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12 M)

P/L

103.71

2.31%

ROE

6.45%

P/VP

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12 M)

P/L

-64.94

2.98%

ROE

-9.23%

P/VP

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12 M)

P/L

91.32

1.76%

ROE

6.50%

P/VP

5.94

ABBV - AbbVie

$ 209.41 16,34% (12 M)

P/L

535.81

3.20%

ROE

-10.51%

P/VP

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12 M)

P/L

26.47

4.17%

ROE

23.91%

P/VP

6.33

Frequently Asked Questions

What is the price of Kala Pharmaceuticals (KALA) today?

The current price of Kala Pharmaceuticals (KALA) is $ 2.71, representing a -98.52% gain over the past year. The stock began the year trading around $ 0.56 and is currently priced at $ 2.71. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kala Pharmaceuticals (KALA) pay dividends?

Kala Pharmaceuticals (KALA) did not pay dividends over the past year.

Is Kala Pharmaceuticals (KALA) a good investment?

Kala Pharmaceuticals (KALA) is currently trading at $ 2.71 with a P/E ratio of 4.25. This represents a 76% premium compared to its historical average P/E. Over the past year, the stock has gained -98.52 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -98.52%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kala Pharmaceuticals (KALA) stock?

You can buy Kala Pharmaceuticals (KALA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KALA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kala Pharmaceuticals (KALA) yield today?

Over the past month, Kala Pharmaceuticals (KALA) has returned -72.75% — -98.52% over the past year, and -99.98% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Kala Pharmaceuticals (KALA) today at the current price of $ 2.71 your total investment would be $ 271.00.

Based on historical performance, the investment would have grown to approximately:

$ 4.01 after 1 year
$ 0.05 after 5 years
$ 271.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KALA

Kala Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KALA

review the fundamentals of Kala Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kala Pharmaceuticals

Kala Pharmaceuticals Inc.

United States

17 years

2017

188

PROFIT X PRICE KALA

Financial Results KALA

KALA cash flow

Asset, Revenue and Profit Growth - KALA

KALA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions